Profile data is unavailable for this security.
About the company
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
- Revenue in NOK (TTM)0.00
- Net income in NOK-54.84m
- Incorporated2012
- Employees12.00
- LocationExact Therapeutics ASOstre Aker vei 19OSLO 0581NorwayNOR
- Websitehttps://www.exact-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lumito AB (publ) | 17.02k | -31.90m | 124.45m | 13.00 | -- | 1.29 | -- | 7,313.17 | -0.1472 | -0.1472 | 0.00008 | 0.4133 | 0.0001 | -- | 2.43 | 1,133.33 | -26.73 | -20.77 | -30.85 | -22.38 | 42,235.47 | -- | -187,433.80 | -- | 1.10 | -14.60 | 0.1715 | -- | -- | -- | 4.56 | -- | -- | -- |
| NextCell Pharma AB | 10.68m | -42.00m | 128.77m | 24.00 | -- | 1.90 | -- | 12.06 | -0.8409 | -0.8409 | 0.2095 | 0.9249 | 0.1254 | 55.56 | 5.31 | 444,362.90 | -49.33 | -35.01 | -55.89 | -37.45 | -247.97 | -304.79 | -393.45 | -468.52 | 6.09 | -- | 0.00 | -- | 5.45 | 42.54 | -5.40 | -- | -27.06 | -- |
| Kancera AB | 0.00 | -53.12m | 130.77m | 5.00 | -- | 1.57 | -- | -- | -0.5955 | -0.5955 | 0.00 | 0.6849 | 0.00 | -- | -- | 0.00 | -56.73 | -54.82 | -66.40 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Biovica International AB | 7.26m | -115.56m | 151.48m | 27.00 | -- | 1.69 | -- | 20.87 | -1.73 | -1.73 | 0.1055 | 1.06 | 0.0584 | 17.30 | 4.76 | 226,593.80 | -92.98 | -51.94 | -110.37 | -58.18 | -394.72 | -576.01 | -1,592.15 | -2,217.41 | 3.47 | -- | 0.0721 | -- | 115.49 | 19.39 | -12.97 | -- | -54.31 | -- |
| Acousort AB | 3.44m | -19.32m | 170.42m | -- | -- | 11.13 | -- | 49.51 | -1.33 | -1.33 | 0.2379 | 1.02 | 0.1461 | 4.08 | 1.96 | -- | -81.99 | -48.62 | -137.70 | -69.77 | -159.41 | -68.05 | -561.21 | -299.58 | 1.91 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
| Biosergen AB | 0.00 | -23.45m | 171.14m | 2.00 | -- | 7.49 | -- | -- | -0.2273 | -0.2273 | 0.00 | 0.0822 | 0.00 | -- | -- | 0.00 | -179.89 | -- | -244.13 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.25 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -54.84m | 182.86m | 12.00 | -- | 10.49 | -- | -- | -1.66 | -1.66 | 0.00 | 0.5435 | 0.00 | -- | -- | -- | -130.29 | -40.21 | -170.98 | -45.67 | -- | -- | -- | -- | -- | -- | 0.0502 | -- | -- | -- | -20.52 | -- | -- | -- |
| Intervacc AB | 9.30m | -77.41m | 192.56m | 15.00 | -- | 1.07 | -- | 20.72 | -1.02 | -1.02 | 0.1226 | 2.38 | 0.0386 | 5.09 | 1.59 | 619,066.70 | -32.15 | -17.62 | -35.27 | -18.77 | -432.03 | -243.59 | -832.82 | -626.90 | 2.26 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| ViroGates A/S | 6.53m | -20.58m | 198.50m | 10.00 | -- | 15.00 | -- | 30.40 | -5.64 | -5.64 | 0.8338 | 1.10 | 0.2935 | 0.4667 | 3.62 | 419,900.00 | -92.50 | -46.58 | -105.88 | -52.09 | 57.25 | 77.91 | -315.15 | -238.01 | 6.13 | -19.84 | 0.4278 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| Xintela AB | 381.38k | -40.87m | 200.40m | -- | -- | -- | -- | 525.47 | -0.0817 | -0.0817 | 0.0008 | -0.0319 | 0.0306 | -- | 0.0493 | -- | -327.65 | -181.06 | -- | -391.61 | 100.00 | -- | -10,717.06 | -235,894.00 | -- | -203.91 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| SenzaGen AB | -100.10bn | -100.10bn | 206.73m | 33.00 | -- | 2.31 | -- | -- | -- | -- | -- | 3.03 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 3.18 | -- | 0.0225 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Lifecare ASA | 15.07m | -59.84m | 208.47m | 32.00 | -- | 0.1789 | -- | 13.83 | -16.49 | -16.49 | 1.51 | 73.51 | 0.1698 | -- | 1.56 | 471,007.80 | -67.36 | -40.00 | -86.96 | -45.26 | -- | -- | -396.68 | -175.53 | -- | -- | 0.1102 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Abliva AB | 137.14k | -102.23m | 217.82m | 6.00 | -- | 2.12 | -- | 1,588.35 | -0.0928 | -0.0928 | 0.0001 | 0.0638 | 0.0013 | -- | 0.0062 | 22,833.33 | -93.81 | -74.59 | -103.87 | -86.98 | -35,826.28 | -- | -74,542.34 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -87.29m | 248.60m | 6.00 | -- | 3.85 | -- | -- | -8.16 | -8.16 | 0.00 | 5.25 | 0.00 | -- | -- | -- | -96.71 | -69.56 | -117.53 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -52.50m | 250.75m | 4.00 | -- | 9.99 | -- | -- | -0.1734 | -0.1734 | 0.00 | 0.0471 | 0.00 | -- | -- | 0.00 | -235.29 | -125.42 | -407.84 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
Data as of Nov 21 2024. Currency figures normalised to Exact Therapeutics AS's reporting currency: Norwegian Krone NOK
5.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Norway)as of 31 Jul 2024 | 1.25m | 3.88% |
| Danske Invest Asset Management ASas of 31 Oct 2024 | 611.58k | 1.91% |
Data from 30 Sep 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
